Energesis Pharmaceuticals

Developer of drugs to treat obesity, diabetes, and related metabolic diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2009 language energesispharma.com

Innovation

7 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 578 times.

YearFilings
20132
20141
20153
20163
20171
20193
20202
20212
20226
20233
20245
20251

Social engagement

Social engagement: 82 social following, 1 post in the last 12 months — top 10% of its industry.

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Accelerator & incubator133%
Other / undisclosed133%

Recent activity

13 Sep 2025
Event
Obesity Science Innovation Conference
Coming soon